FR2445147A1 - Nouvel antibiotique du type polyether comportant un groupe cetone a, b-insature, son procede de production et ses applications - Google Patents

Nouvel antibiotique du type polyether comportant un groupe cetone a, b-insature, son procede de production et ses applications

Info

Publication number
FR2445147A1
FR2445147A1 FR7932002A FR7932002A FR2445147A1 FR 2445147 A1 FR2445147 A1 FR 2445147A1 FR 7932002 A FR7932002 A FR 7932002A FR 7932002 A FR7932002 A FR 7932002A FR 2445147 A1 FR2445147 A1 FR 2445147A1
Authority
FR
France
Prior art keywords
applications
producing
same
ketone group
unsaturated ketone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7932002A
Other languages
English (en)
Other versions
FR2445147B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taisho Pharmaceutical Co Ltd
Original Assignee
Taisho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taisho Pharmaceutical Co Ltd filed Critical Taisho Pharmaceutical Co Ltd
Publication of FR2445147A1 publication Critical patent/FR2445147A1/fr
Application granted granted Critical
Publication of FR2445147B1 publication Critical patent/FR2445147B1/fr
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/01—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing oxygen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/18—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms containing at least two hetero rings condensed among themselves or condensed with a common carbocyclic ring system, e.g. rifamycin
    • C12P17/181—Heterocyclic compounds containing oxygen atoms as the only ring heteroatoms in the condensed system, e.g. Salinomycin, Septamycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/445—The saccharide radical is condensed with a heterocyclic radical, e.g. everninomycin, papulacandin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/44—Preparation of O-glycosides, e.g. glucosides
    • C12P19/60—Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces
    • C12R2001/55—Streptomyces hygroscopicus
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Saccharide Compounds (AREA)

Abstract

Le nouveau composé selon l'invention dénommé TM-531 répond à la formule :
FR7932002A 1978-12-29 1979-12-28 Nouvel antibiotique du type polyether comportant un groupe cetone a, b-insature, son procede de production et ses applications Granted FR2445147A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP16411878A JPS5592387A (en) 1978-12-29 1978-12-29 Antibiotic substance tm-531

Publications (2)

Publication Number Publication Date
FR2445147A1 true FR2445147A1 (fr) 1980-07-25
FR2445147B1 FR2445147B1 (fr) 1984-02-17

Family

ID=15787085

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7932002A Granted FR2445147A1 (fr) 1978-12-29 1979-12-28 Nouvel antibiotique du type polyether comportant un groupe cetone a, b-insature, son procede de production et ses applications

Country Status (6)

Country Link
US (1) US4269971A (fr)
JP (1) JPS5592387A (fr)
DE (1) DE2952520A1 (fr)
FR (1) FR2445147A1 (fr)
GB (1) GB2041360B (fr)
IT (1) IT7951223A0 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048585A1 (fr) * 1980-09-16 1982-03-31 Taisho Pharmaceutical Co. Ltd Antibiotiques TM-531B et TM-531C

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5622782A (en) 1979-08-03 1981-03-03 Kyowa Hakko Kogyo Co Ltd Dc-38-v and its preparation
JPS577492A (en) 1980-06-13 1982-01-14 Shionogi & Co Ltd K-41 derivative
JPS5758687A (en) * 1980-09-27 1982-04-08 Taisho Pharmaceut Co Ltd Antibiotic
US4361649A (en) * 1981-07-20 1982-11-30 Pfizer Inc. Polycyclic ether antibiotic
US4533553A (en) * 1981-07-20 1985-08-06 Pfizer Inc. Polycyclic ether antibiotic
US4431801A (en) * 1981-07-20 1984-02-14 Pfizer Inc. Polycyclic ether antibiotic
GB8307847D0 (en) * 1983-03-22 1983-04-27 Lepetit Spa Antibiotics l 17054 and l 17046
US4628046A (en) * 1983-06-20 1986-12-09 American Cyanamid Company Antibiotic LL-C23201δ
US4510317A (en) * 1983-07-28 1985-04-09 Hoffmann-La Roche Inc. Antibiotic X-14934A
US4552843A (en) * 1984-02-17 1985-11-12 Pfizer Inc. Process for producing an acidic polycyclic ether antibiotic by cultivation of a novel strain of Streptomyces endus subspecies aureus
US4625041A (en) * 1984-02-17 1986-11-25 Pfizer Inc. Acidic polycyclic ether antibiotic
US5028537A (en) * 1984-03-26 1991-07-02 Merck & Co. Inc. Novel antifungal substances and process for their production
WO2001081339A1 (fr) * 2000-04-26 2001-11-01 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Composes pour le traitement ou la prevention du paludisme et procedes pour le traitement du paludisme
KR100634874B1 (ko) 2004-08-20 2006-10-16 충남대학교산학협력단 신규 미생물 스트렙토마이세스 에스피 ｓｈ09 및 이를이용한 흰가루병을 포함하는 식물진균병 방제방법
CN102870821A (zh) * 2012-09-23 2013-01-16 江苏丘陵地区镇江农业科学研究所 黄麻链霉菌nf0919菌株代谢产物在防治黄瓜病害上的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4138481A (en) * 1976-06-30 1979-02-06 American Cyanamid Company Antibiotic BL580Δ and method of use

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
EXBK/75 *
EXBK/80 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0048585A1 (fr) * 1980-09-16 1982-03-31 Taisho Pharmaceutical Co. Ltd Antibiotiques TM-531B et TM-531C

Also Published As

Publication number Publication date
GB2041360A (en) 1980-09-10
IT7951223A0 (it) 1979-12-28
GB2041360B (en) 1983-01-12
US4269971A (en) 1981-05-26
JPS5592387A (en) 1980-07-12
FR2445147B1 (fr) 1984-02-17
DE2952520A1 (de) 1980-07-10

Similar Documents

Publication Publication Date Title
FR2445147A1 (fr) Nouvel antibiotique du type polyether comportant un groupe cetone a, b-insature, son procede de production et ses applications
FR2361902A1 (fr) Derives de la glucosamine et leur procede de fabrication
FR2401165A1 (fr) Procede de preparation d'analogues de thiadiazolylcephalosporine et nouveaux produits ainsi obtenus, a activite antibacterienne
FR2357553A1 (fr) Procede de preparation de benzothiazoles
FR2372818A1 (fr) Acide 5-(hydroxy (substitue) methyl)-2,3-dihydrobenzofuran-2-carboxylique et ses derives utiles comme medicaments
FR2280650A1 (fr) Procede de fabrication d'oligomeres a partir d'alphaolefines lineaires, leur hydrogenation ulterieure et produits satures ainsi obtenus
FR2335507A1 (fr) Procede de production d'intermediaires de synthese de dibenzo(b,d)pyranes
YU40802B (en) New process for producing substituted 1,2,3,5 tetrahydromiozo (2,1-b) guinazoline-2-one
CS179949B2 (en) Method for production of novel d-homopregn-4-ene 3,20-diones
FR2401148A1 (fr) Procede de preparation de 1-amino-3-aryloxy-2-propanols
BE832129A (fr) Procede de fabrication de phenyl-methylcarbinol par hydrogenation de l'acetophenone
FR2381733A1 (fr) Procede de preparation de m-bromo-a,a,a-trifluorotoluenes
BE888562A (fr) Procede de production d'une preparation enzymatique de fructosyl-transferase,
FR2385670A1 (fr) Procede de preparation de 2,2-dimethylolalcanals
ES459052A1 (es) Un procedimiento para la produccion de la mezcla antibioticaa-35512.
ES486706A1 (es) Un procedimiento de purificacion de acido dihidroxi-3 ,7 ,- (5 )colanico
EG12925A (en) Process for manufacturing 3,5 ditert,buttyl,buttyl-4-hydroxybenzoldehyde by formation of 2,6-ditert,butylphenol
ATE30159T1 (de) Anthracyclinderivate, verfahren zu ihrer herstellung ausgehend von einem stamm von mikroorganismen, der neue stamm streptomyces cyaneus und die verwendung der anthracyclinderivate als pharmazeutische praeparate.
FR2360571A2 (fr) Procede de preparation d'hemiesters sulfuriques
FR2446841A1 (fr) Procede de preparation de 1a,3b-dihydroxy-d5-steroides
FR2375180A1 (fr) Procede de preparation de cetones par rearrangement de cetones
FR2359133A1 (fr) Procede de preparation de (vinyl 2,2-disubstitue)-g-butyrolactones
IT1160087B (it) Procedimento per la produzione dell'antibiotico ottenuto coltivando un microorganismo del genere nocardia
BE821144A (fr) Procede de fabrication d'un succedane d'amuse-gueule
BE851872A (fr) Procede de production d'un antibiotique

Legal Events

Date Code Title Description
ST Notification of lapse